Immune Checkpoint Blockade – How Does It Work in Brain Metastases?
Immune checkpoints restrain the immune system following its activation and their inhibition unleashes anti-tumor immune responses. Immune checkpoint inhibitors revolutionized the treatment of several cancer types, including melanoma, and immune checkpoint blockade with anti-PD-1 and anti-CTLA-4 anti...
Main Authors: | Mihaela Lorger, Tereza Andreou, Christopher Fife, Fiona James |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2019.00282/full |
Similar Items
-
Predictive biomarkers for tumor immune checkpoint blockade
by: Tong M, et al.
Published: (2018-10-01) -
Advances of immune checkpoint blockade in the treatment of advanced gastric cancer
by: Zhi-Jia Sun, et al.
Published: (2017-06-01) -
Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy
by: Qi-jie Zhang, et al.
Published: (2021-04-01) -
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases
by: Eric J. Lehrer, et al.
Published: (2018-10-01) -
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
by: Florent Petitprez, et al.
Published: (2020-05-01)